Epidemiology

You have full text access to this OnlineOpen article

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis

  1. Camille C. R. Ragin1,2,†,*,
  2. Emanuela Taioli1,2

Article first published online: 1 JUN 2007

DOI: 10.1002/ijc.22851

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 8, pages 1813–1820, 15 October 2007

Additional Information

How to Cite

Ragin, C. C. R. and Taioli, E. (2007), Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int. J. Cancer, 121: 1813–1820. doi: 10.1002/ijc.22851

Author Information

  1. 1

    Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA

  2. 2

    Division of Cancer Prevention and Population Science, University of Pittsburgh Cancer Institute, Pittsburgh, PA

  1. †

    Fax: +412-623-3878

*Division of Cancer Prevention and Population Science, University of Pittsburgh Cancer Institute, 5150 Centre Avenue, Fourth Floor, Pittsburgh, PA 15261, USA

Publication History

  1. Issue published online: 14 AUG 2007
  2. Article first published online: 1 JUN 2007
  3. Manuscript Accepted: 17 APR 2007
  4. Manuscript Received: 2 MAR 2007

Funded by

  • NIH. Grant Numbers: P50CA097190, 5P50CA097190
  • GLMA

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (171K)

References

  • 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66.
    Direct Link:
  • 2
    Surveillance Research Program, National Cancer Institute SEER*Stat software, 2006. www.seer.cancer.gov/seerstat.
  • 3
    Cooper JS,Pajak TF,Rubin P,Tupchong L,Brady LW,Leibel SA,Laramore GE,Marcial VA,Davis LW,Cox JD. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989; 17: 449–56.
  • 4
    Leon X,Quer M,Diez S,Orus C,Lopez-Pousa A,Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21: 204–10.
    Direct Link:
  • 5
    Rafferty MA,O'Dwyer TP. Secondary primary malignancies in head and neck squamous cell carcinoma. J Laryngol Otol 2001; 115: 988–91.
  • 6
    Haughey BH,Gates GA,Arfken CL,Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101: 105–112.
  • 7
    Panosetti E,Luboinski B,Mamelle G,Richard JM. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study. Laryngoscope 1989; 99: 1267–73.
    Direct Link:
  • 8
    Ragin CC,Taioli E,Weissfeld JL,White JS,Rossie KM,Modugno F,Gollin SM. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 2006; 95: 1432–8.
  • 9
    Schlecht NF. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. Oncol Rep 2005; 14: 1239–47.
  • 10
    Szentirmay Z,Polus K,Tamas L,Szentkuti G,Kurcsics J,Csernak E,Toth E,Kasler M. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev 2005; 24: 19–34.
  • 11
    Massano J,Regateiro FS,Januario G,Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67–76.
  • 12
    Klussmann JP,Gultekin E,Weissenborn SJ,Wieland U,Dries V,Dienes HP,Eckel HE,Pfister HJ,Fuchs PG. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747–53.
  • 13
    Sisk EA,Soltys SG,Zhu S,Fisher SG,Carey TE,Bradford CR. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 2002; 24: 841–9.
    Direct Link:
  • 14
    Dahlstrand HM,Dalianis T. Presence and influence of human papillomaviruses (HPV) in Tonsillar cancer. Adv Cancer Res 2005; 93: 59–89.
  • 15
    Sugiyama M,Bhawal UK,Kawamura M,Ishioka Y,Shigeishi H,Higashikawa K,Kamata N. Human papillomavirus-16 in oral squamous cell carcinoma: Clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 2007; 45: 116–22.
  • 16
    Dahlgren L,Mellin H,Wangsa D,Heselmeyer-Haddad K,Bjornestal L,Lindholm J,Munck-Wikland E,Auer G,Ried T,Dalianis T. Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 2003; 107: 244–9.
    Direct Link:
  • 17
    Mellin H,Dahlgren L,Munck-Wikland E,Lindholm J,Rabbani H,Kalantari M,Dalianis T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002; 102: 152–8.
    Direct Link:
  • 18
    Ringstrom E,Peters E,Hasegawa M,Posner M,Liu M,Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 3187–92.
  • 19
    Lindel K,Beer KT,Laissue J,Greiner RH,Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805–13.
    Direct Link:
  • 20
    Portugal LG,Goldenberg JD,Wenig BL,Ferrer KT,Nodzenski E,Sabnani JB,Javier C,Weichselbaum RR,Vokes EE. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1997; 123: 1230–4.
  • 21
    Haraf DJ,Nodzenski E,Brachman D,Mick R,Montag A,Graves D,Vokes EE,Weichselbaum RR. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996; 2: 755–62.
  • 22
    Chiba I,Shindoh M,Yasuda M,Yamazaki Y,Amemiya A,Sato Y,Fujinaga K,Notani K,Fukuda H. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996; 12: 1663–68.
  • 23
    Shima K,Kobayashi I,Saito I,Kiyoshima T,Matsuo K,Ozeki S,Ohishi M,Sakai H. Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. Br J Oral Maxillofac Surg 2000; 38: 445–50.
  • 24
    Vlachtsis K,Nikolaou A,Markou K,Fountzilas G,Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol 2005; 262: 890–8.
  • 25
    Brandwein M,Zeitlin J,Nuovo GJ,MacConnell P,Bodian C,Urken M,Biller H. HPV detection using “hot start” polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994; 7: 720–7.
  • 26
    Weinberger PM,Yu Z,Haffty BG,Kowalski D,Harigopal M,Brandsma J,Sasaki C,Joe J,Camp RL,Rimm DL,Psyrri A. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736–47.
  • 27
    Clayman GL,Stewart MG,Weber RS,el Naggar AK,Grimm EA. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg 1994; 120: 743–8.
  • 28
    Dahlgren L,Dahlstrand HM,Lindquist D,Hogmo A,Bjornestal L,Lindholm J,Lundberg B,Dalianis T,Munck-Wikland E. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004; 112: 1015–19.
    Direct Link:
  • 29
    Parmar MK,Torri V,Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815–34.
    Direct Link:
  • 30
    Pintos J,Franco EL,Black MJ,Bergeron J,Arella M. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 1999; 85: 1903–9.
  • 31
    Koch WM,Lango M,Sewell D,Zahurak M,Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999; 109: 1544–51.
    Direct Link:
  • 32
    Gillison ML,Koch WM,Capone RB,Spafford M,Westra WH,Wu L,Zahurak ML,Daniel RW,Viglione M,Symer DE,Shah KV,Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709–20.
  • 33
    Azzimonti B,Pagano M,Mondini M,De Andrea M,Valente G,Monga G,Tommasino M,Aluffi P,Landolfo S,Gariglio M. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology 2004; 45: 560–72.
    Direct Link:
  • 34
    Koskinen WJ,Chen RW,Leivo I,Makitie A,Back L,Kontio R,Suuronen R,Lindqvist C,Auvinen E,Molijn A,Quint WG,Vaheri A, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 107: 401–6.
    Direct Link:
  • 35
    Sisk EA,Bradford CR,Jacob A,Yian CH,Staton KM,Tang G,Harris MO,Carey TE,Lancaster WD,Gregoire L. Human papillomavirus infection in “young” versus “old” patients with squamous cell carcinoma of the head and neck. Head Neck 2000; 22: 649–57.
    Direct Link:
  • 36
    Snijders PJ,Scholes AG,Hart CA,Jones AS,Vaughan ED,Woolgar JA,Meijer CJ,Walboomers JM,Field JK. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996; 66: 464–9.
    Direct Link:
  • 37
    Li W,Thompson CH,O'Brien CJ,McNeil EB,Scolyer RA,Cossart YE,Veness MJ,Walker DM,Morgan GJ,Rose BR. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003; 106: 553–8.
    Direct Link:
  • 38
    Na II,Kang HJ,Cho SY,Koh JS,Lee JK,Lee BC,Lee GH,Lee YS,Yoo HJ,Ryoo BY. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Eur J Cancer 2007; 43: 520–6.
  • 39
    Licitra L,Perrone F,Bossi P,Suardi S,Mariani L,Artusi R,Oggionni M,Rossini C,Cantu G,Squadrelli M,Quattrone P,Locati LD, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630–36.
  • 40
    De Petrini M,Ritta M,Schena M,Chiusa L,Campisi P,Giordano C,Landolfo V,Pecorari G,Landolfo S. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression. New Microbiol 2006; 29: 25–33.
  • 41
    Baez A,Almodovar JI,Cantor A,Celestin F,Cruz-Cruz L,Fonseca S,Trinidad-Pinedo J,Vega W. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population. Head Neck 2004; 26: 778–84.
    Direct Link:
  • 42
    Ritchie JM,Smith EM,Summersgill KF,Hoffman HT,Wang D,Klussmann JP,Turek LP,Haugen TH. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336–44.
    Direct Link:
  • 43
    Schwartz SR,Yueh B,McDougall JK,Daling JR,Schwartz SM. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001; 125: 1–9.
  • 44
    Friesland S,Mellin H,Munck-Wikland E,Nilsson A,Lindholm J,Dalianis T,Lewensohn R. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma—relation to radiotherapy response and survival. Anticancer Res 2001; 21: 529–34.
  • 45
    Mellin H,Friesland S,Lewensohn R,Dalianis T,Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000; 89: 300–4.
    Direct Link:
  • 46
    Strome SE,Savva A,Brissett AE,Gostout BS,Lewis J,Clayton AC,McGovern R,Weaver AL,Persing D,Kasperbauer JL. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 2002; 8: 1093–100.
  • 47
    Riethdorf S,Friedrich RE,Ostwald C,Barten M,Gogacz P,Gundlach KK,Schlechte H,Becker J,Bregenzer T,Riethdorf L,Loning T. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997; 26: 315–21.
    Direct Link:
  • 48
    Paz IB,Cook N,Odom-Maryon T,Xie Y,Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997; 79: 595–604.
    Direct Link:
  • 49
    Hoffmann M,Gorogh T,Gottschlich S,Lohrey C,Rittgen W,Ambrosch P,Schwarz E,Kahn T. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 2005; 218: 199–206.
  • 50
    Kozomara R,Jovic N,Magic Z,Brankovic-Magic M,Minic V. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Cranio-Maxillofac Surg 2005; 33: 342–348.
  • 51
    Wittekindt C,Gultekin E,Weissenborn SJ,Dienes HP,Pfister HJ,Klussmann JP. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv Otorhinolaryngol 2005; 62: 72–80.
  • 52
    Reimers N,Kasper HU,Weissenborn SJ,Stutzer H,Preuss SF,Hoffmann TK,Speel EJ,Dienes HP,Pfister HJ,Guntinas-Lichius O,Klussmann JP. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731–8.
    Direct Link:
  • 53
    Kreimer AR,Clifford GM,Boyle P,Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467–75.
  • 54
    Hobbs CG,Sterne JA,Bailey M,Heyderman RS,Birchall MA,Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31: 259–66.
    Direct Link:
  • 55
    Wiest T,Schwarz E,Enders C,Flechtenmacher C,Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002; 21: 1510–17.
  • 56
    Peltenburg LT. Radiosensitivity of tumor cells. Oncogenes and apoptosis. Q J Nucl Med 2000; 44: 355–64.
  • 57
    Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 2001; 23: 238–53.
    Direct Link:
  • 58
    Huang X,Gollin SM,Raja S,Godfrey TE. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci 2002; 99: 11369–74.
  • 59
    Fujii M,Ishiguro R,Yamashita T,Tashiro M. Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett 2001; 172: 187–92.
  • 60
    Akervall JA,Michalides RJ,Mineta H,Balm A,Borg A,Dictor MR,Jin Y,Loftus B,Mertens F,Wennerberg JP. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997; 79: 380–9.
    Direct Link:
  • 61
    Rodrigo JP,Garcia LA,Ramos S,Lazo PS,Suarez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2000; 6: 3177–82.
  • 62
    Namazie A,Alavi S,Olopade OI,Pauletti G,Aghamohammadi N,Aghamohammadi M,Gornbein JA,Calcaterra TC,Slamon DJ,Wang MB,Srivatsan ES. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002; 112: 472–81.
    Direct Link:
View Full Article (HTML) Get PDF (171K)